Mid-term outcomes of gastric bypass weight loss failure to duodenal switch

Surve, Amit; Zaveri, Hinali; Cottam, Daniel; Belnap, Legrand; Medlin, Walter; Cottam, Austin

doi:10.1016/j.soard.2016.03.021

Cited by 45 publications

(14 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently, there have been several reports on the outcomes of SADI-S procedure [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]. One of the articles published by Neichoy et al [16] on the midterm outcomes of SADI-S reported EWL of 88% at 24 months.…”

Section: Discussionmentioning

confidence: 99%

“…Based on clinical knowledge, expert opinion, and published peer-reviewed scientific evidence, the International Federation for the Surgery of Obesity and Metabolic Disorders considered the SADI-S (and its variant [stomach intestinal pylorus-sparing surgery]) an established bariatric procedure [14]. In recent years, there have been few reports on the short-and mid-term outcomes of this procedure [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]. In terms of weight loss, the SADI-S and RYGB had statistically similar weight loss; however, the weight loss was statistically higher in patients undergoing SADI-S procedure than SG [21,30].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center

Enochs

Bull

Surve³

et al. 2020

Surgery for Obesity and Related Diseases

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center

Enochs

Bull

Surve³

et al. 2020

Surgery for Obesity and Related Diseases

Self Cite

View full text Add to dashboard Cite

“…Weight loss failure, weight recidivism, and recurrent comorbidities after the RYGB are challenging problems for bariatric surgeons. 10 – 12 Currently, there is no clear concurrence about what is the best bariatric procedure to be performed.…”

Section: Discussionmentioning

confidence: 99%

Stomach Intestinal Pylorus-Sparing Surgery for Morbid Obesity

Neichoy

Schniederjan

Cottam³

et al. 2018

JSLS

Self Cite

View full text Add to dashboard Cite

Background and Objective:The Roux-en-Y duodenal switch (RYDS) is one of the most efficient forms of bariatric surgery. However, diarrhea, malnutrition, ulcers, and internal hernias have hampered its widespread adoption. The stomach intestinal pylorus-sparing (SIPS) procedure was developed to alleviate these sequelae while retaining the same weight loss as the RYDS. In this study, we report our midterm experience with this novel technique.Methods:Retrospective analysis was performed on data from 225 patients who underwent a primary SIPS procedure by 2 surgeons at a single center from October 2013 through December 2016.Results:Two hundred twenty-five patients were identified for analysis. The mean preoperative body mass index (BMI) was 52.4 ± 9.1 kg/m2. Forty-eight patients were beyond 2 years after surgery, with data available for 30 patients (62.5% follow-up). Three patients were lost to follow-up. At 2 years, the patients had an average change in BMI of 26.6 U (kg/m2) with an average of 88.7% of excess weight loss. Three deaths were related to the surgery. The most common short-term complication was a leak (2.2%), whereas the most common long-term complication was diarrhea (2.2%).Conclusion:In conclusion, SIPS surgery is a safe procedure with favorable weight loss outcomes at 2 years.

show abstract

“…The most widely used options after RYGB is the conversion to a long-limb (distal) RYGB, pouch resizing, banding of the pouch or endoscopic narrowing of the pouch anastomosis (176,177,178). However, the conversion of the failed RYGB to BPD-DS have also been successfully reported in two case series (179,180). The outcomes of these revisions are in the short term acceptable but there are only few long-term results.…”

Section: Discussionmentioning

confidence: 99%

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass

Billeter

Herrera

Scheurlen

et al. 2018

European Journal of Endocrinology

View full text Add to dashboard Cite

Obesity and its associated comorbidities have become one of the largest challenges for health care in the near future. Conservative therapy for obesity and related comorbidities has a very high failure rate and poor long-term results. Similarly, the conservative and medical management of the majority of metabolic diseases such as type 2 diabetes mellitus are only able to slow down disease progression but have no causal effect on the disease process. Obesity surgery has evolved as a highly effective therapy for severe obesity achieving long-lasting weight loss. Furthermore, several studies have demonstrated the beneficial effects of obesity surgery on reduction of overall mortality, reduction of cardiovascular events and superior control of obesity-related diseases such as type 2 diabetes mellitus, dyslipidemia and also the non-alcoholic steatohepatitis compared to medical therapy. Based on these findings, the term 'metabolic surgery' with the focus on treating metabolic diseases independent of body weight has been coined. Of great interest are recent studies that show that even existing complications of metabolic diseases such as diabetic nephropathy or the non-alcoholic steatohepatitis can be reversed by metabolic surgery. Although metabolic surgery has proven to be a safe and effective treatment for obesity, resolution of comorbidities and enhancing quality of life, it is still uncertain and unclear, which surgical procedure is the most effective to achieve these metabolic effects. The aim of this review is to compare the effects of the two currently most widely used metabolic operations, the Roux-en-Y gastric bypass and the sleeve gastrectomy in the treatment of obesity and its related comorbidities.

show abstract

Mid-term outcomes of gastric bypass weight loss failure to duodenal switch

Cited by 45 publications

References 29 publications

Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center

Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center

Stomach Intestinal Pylorus-Sparing Surgery for Morbid Obesity

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass

Contact Info

Product

Resources

About